TFF Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
TFF Pharmaceuticals, Inc. has filed 317 SEC EDGAR filings since 27 Mar 2018

SEC filing history

Showing 151-175 of 317 matching filings.

Per page
25
Current page
7
10-Q File 001-39102

QUARTERLY REPORT

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
14 Nov 2022
Reporting date
14 Nov 2022
Next action
Verify source filing
DEFA14A File 001-39102

DEFINITIVE ADDITIONAL MATERIALS

Filing date
06 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
30 Sep 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
4

4 filing

Filing date
30 Sep 2022
Reporting date
29 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39102

DEFINITIVE PROXY STATEMENT

Filing date
21 Sep 2022
Reporting date
07 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
11 Aug 2022
Reporting date
11 Aug 2022
Next action
Verify source filing
10-Q File 001-39102

QUARTERLY REPORT

Filing date
11 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
10 Jun 2022
Reporting date
10 Jun 2022
Next action
Verify source filing
424B5 File 333-249870

PROSPECTUS SUPPLEMENT

Filing date
10 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2022
Reporting date
18 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 May 2022
Reporting date
16 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 May 2022
Reporting date
16 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 May 2022
Reporting date
16 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 May 2022
Reporting date
16 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 May 2022
Reporting date
16 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-39102

10-Q filing

Filing date
11 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
11 May 2022
Reporting date
11 May 2022
Next action
Verify source filing
4

4 filing

Filing date
04 Apr 2022
Reporting date
04 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
04 Apr 2022
Reporting date
25 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-39102

ANNUAL REPORT

Filing date
24 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
24 Mar 2022
Reporting date
24 Mar 2022
Next action
Verify source filing
SC 13G/A File 005-91311

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91311

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .